Bausch Health Companies (BHC) Current Assets (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Current Assets came in at $6.5 billion in Q2 2026, little changed year-over-year from $6.5 billion in Q2 2025, and up 9.1% quarter-over-quarter from $6.0 billion in Q1 2026.
Analysis
Bausch Health Companies (BHC) Current Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Current Assets across 18 years of filings, most recently posting $6.5 billion for Q2 2026.
- In Q2 2026, Current Assets changed 0.12% year-over-year to $6.5 billion; the TTM figure through Jun 2026 stood at $6.5 billion (changed 0.12% YoY), while the FY2025 annual figure was $6.2 billion, up 6.63% from the prior year.
- Current Assets came in at $6.5 billion for Q2 2026 at Bausch Health Companies, up from $6.0 billion in the prior quarter.
- In the past five years, Current Assets ranged from a high of $6.5 billion in Q2 2026 to a low of $4.0 billion in Q3 2022.
- Average Current Assets over 5 years is $5.4 billion, with a median of $5.5 billion recorded in 2022.
- The largest YoY upside for Current Assets was 31.76% in 2023 against a maximum downside of 27.4% in 2023.
- Over 5 years, Current Assets stood at $4.2 billion in 2022, then jumped by 31.76% to $5.6 billion in 2023, then climbed by 3.18% to $5.8 billion in 2024, then rose by 6.63% to $6.2 billion in 2025, then climbed by 5.93% to $6.5 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $6.5 billion in Q2 2026, $6.0 billion in Q1 2026, and $6.2 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 13.76 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 10.06 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 3.16 Bn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 1.95 Bn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 6.52 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 544.97 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 825.43 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 630.95 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 72.50 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | 6.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.52 Bn |
| Mar 31, 2026 | 5.98 Bn |
| Dec 31, 2025 | 6.16 Bn |
| Sep 30, 2025 | 6.25 Bn |
| Jun 30, 2025 | 6.51 Bn |
| Mar 31, 2025 | 5.73 Bn |
| Dec 31, 2024 | 5.77 Bn |
| Sep 30, 2024 | 5.35 Bn |
| Jun 30, 2024 | 5.21 Bn |
| Mar 31, 2024 | 5.40 Bn |
| Dec 31, 2023 | 5.60 Bn |
| Sep 30, 2023 | 5.05 Bn |
| Jun 30, 2023 | 4.46 Bn |
| Mar 31, 2023 | 4.24 Bn |
| Dec 31, 2022 | 4.25 Bn |
| Sep 30, 2022 | 4.01 Bn |
| Jun 30, 2022 | 5.42 Bn |
| Mar 31, 2022 | 5.84 Bn |
| Dec 31, 2021 | 5.61 Bn |
| Sep 30, 2021 | 5.32 Bn |